AgendaSpeakersAttendeesOverview WSGR website


Conference Agenda

Thursday June 25, 2015
Sharon Heights Golf and Country Club
2900 Sand Hill Road
Menlo Park, CA

6:00 – 9:00 p.m.

Medical Device Dinner Interview with Steve Blank
Join David Cassak in conversation with Steve Blank on the Lean LaunchPad approach to building Medtech startups. Steve is an entrepreneur with eight tech startups under his belt who retired to become a writer and educator and in the process launched the “Lean Startup” movement. Today Steve lectures on entrepreneurship at Berkeley, Stanford, Columbia, NYU and UCSF, and in 2009 was awarded the Stanford University Undergraduate Teaching Award in Management Science.

Friday June 26, 2015

Palace Hotel
2 New Montgomery Street
San Francisco, CA

7:00 – 8:00 a.m.

Conference Registration and Continental Breakfast

8:00 – 8:10 a.m.

Welcome, Casey McGlynn, Wilson Sonsini Goodrich & Rosati

8:10 – 9:10 a.m.

Venture Capital Today
Getting a new medical device company funded is harder today. An ever-shrinking pool of investors interested in early-stage life science investing, larger capital requirements due to prolonged regulatory and reimbursement timelines, and the need for true sales traction to garner the attention of potential corporate acquirers have all become the hallmarks of the current financing environment. How are investors adapting their financing strategies and business models to accommodate these realities and position themselves for long-term success? Join a panel of Medtech investors to explore their approaches to investing in these changing times.

9:10 – 9:30 a.m.


9:30 – 10:30 a.m.

Breakout Session 1

Innovative Deal Structures
Several investors and CEOs will review recent corporate partnering transactions. Learn about how young venture backed companies worked with large Medtech consolidators to create win-win structures. Listen to a discussion on key business terms in early and late stage deals. Join a discussion about the differing structures and key terms involved in these transactions.

International Tract - Asia
Join a panel of experienced executives who have successfully raised capital in Asia. Meet international investors and advisors who can help you fund your company or help you to establish a business in Asia. Learn how these transactions are structured and the reasons that draw international capital to the US and US entrepreneurs to Asia.

Important M&A Deals
An investment banker, two successful CEOs, and a corporate development executive from a Medtech consolidator will join this panel to explore structured M&A transactions--deals involving earnouts and milestones. Recent deal terms will be explored as well as a retrospective look at how successful these transactions are in delivering value to shareholders and acquirers. Join us for a lively discussion about these transactions from the view of both the buyer and seller..

10:30 – 10:50 a.m.


10:50 – 11:50 a.m

Breakout Session 2

Corporate Investors
Meet corporate investors from two large Medtech consolidators. Learn about the interests of each company in corporate partnering with emerging Medtech companies. Hear about the typical arrangements corporate acquirers like to structure and the therapeutic areas of interest to them today. This panel will also include information on how these arrangements can come undone and ways to make sure the deal ends up as a win-win transaction that will benefit management, investors and the acquirers.

What Payors and Providers Want
Today more than ever, Medtech companies must demonstrate how their devices will both improve care and save the healthcare system money. The Affordable Care Act has shifted the economic risks of care from the payors to the providers. Additionally the consolidation of providers is creating much greater market power. These changes are forcing Medtech companies to find new ways to define clinical and economic benefit. Join this group of Payors and Providers to learn what attributes your products need to be successful in this new world.

Regulatory-Successful De Novo 510K Strategies
Learn the secrets of the De Novo 510k Pathway. Interestingly this alternative to the lengthy premarket approval process has never quite caught on among device makers. In fact, it remains one of the least traveled routes to market for new devices. Meet the executives from emerging Medtech companies as they explain their experience with this pathway and today’s slimmed down process to approval. Is the DeNovo Pathway right for your device? Ask the experts on this panel.

11:50 a.m. – 12:10 p.m.


12:10 – 1:10 p.m.

Breakout Session 3

Commercialization Strategies
The CEOs on this panel have built and sold some of the most important Medtech companies started over the last 30 years. Join them to discuss how to create a world class business today. The panel will explore team building, financing, product development, clinical development and commercialization. The discussion will look at company building today and how best practices are changing. Learn about some of the alternative approaches that startups are experimenting with as they birth the next generation of Medtech businesses.

International Tract – China
China’s exploding growth is creating a new middle class that will soon be purchasing more healthcare services than Europe. With the difficult regulatory and reimbursement environment in the U.S., the time for medical technology companies to look to China for revenue growth and capital is now. This panel will explore the experiences of several small U.S. Medtech companies that have raised money from Chinese funds or opened shop in China. It will cover how best to navigate the complexities and challenges of China in order to successfully access the burgeoning Chinese medical device market. This panel will include executives with experience operating businesses, distributing products, and raising and developing capital in China.

Lean LaunchPad
In today’s tough funding climate, innovation in science and technology is not enough. The Lean LaunchPad approach to building Medtech startups focuses on getting founders “out of the building” to solicit direct feedback from customers and critical stakeholders, providing an early testing of core hypotheses and allowing immediate refinements in critical business model assumptions. This “Lean” approach shifts startup thinking from writing business plans and immediate execution to the early testing of critical hypotheses about business, allowing adjustments or pivots on little or no capital. Join Steve Bank and Allan May and several CEOs as they discuss the Lean LaunchPad Concept and the things that entrepreneurs need to have in place before they start to look for money.

1:10 – 2:40 p.m.

Lunch and David Cassak Interview

2:40 – 3:40 p.m.

Breakout Session 4

Medtech IPO’s Are Back
Several Medtech companies have completed IPOs this year and underwriters are actively pitching IPOs to mature Medtech companies. From this vantage point we reach mid-year 2015 with an expanding IPO market for high quality Medtech companies. With this as a background, our panel will explore current investor appetite for Medtech IPOs, the status of the emerging window for public offerings and the likely minimum requirements to be considered an attractive Medtech IPO candidate.

Patient Monitoring – Cutting Through the Hype
There is so much hype surrounding remote patient monitoring (RPM) and related buzz terms--like wearables, mobile apps, big data, the Internet of Things (IoT), and mHealth--that sometimes it is difficult to separate hyperbole from reality. What opportunities does RPM really afford medical device makers? What should they do to take advantage? How do wearables fit into the equation? Should the Medtech industry fear or embrace the involvement of tech titans like Google and Apple? Join a panel of experts from tech and Medtech as they explore the role of remote patient monitoring in our future.

Managing Your Patent Portfolio
Developing the world's best medical technology should be enough, but you're also expected to both patent it and defend it within a shrinking budget. Join a panel of medical technology experts, including a successful serial entrepreneur and experienced in-house and outside patent counsel as they discuss how to build value into an IP portfolio while managing costs in today's challenging Medtech environment. The panel will discuss successful strategies for preparing and prosecuting patent applications inside and outside the US as well as facing the patents of competitors in the most cost-effective ways possible. 

3:40 – 4:00 p.m.


4:00– 5:00 p.m.

Medtech Idol
A group of early stage companies will present their pitch to a group of active medical device investors. These companies will vie for the title of Medtech Idol. The investors will evaluate each of the presentations and give feedback to each of the companies that present, and the audience will select the winner using electronic polling. The winner will receive recognition at an awards ceremony during the conference. They will also get a presenting slot at the upcoming AVAMED Annual Meeting. For those interested in applying, please submit an application at

5:00 – 6:30 p.m.

Venture Capital Uncorked
Join Wilson Sonsini Goodrich & Rosati for wine tasting after the conference. We will be sampling wines from various wineries, with venture capitalists serving as your sommeliers for the event. This is your chance to try some great wine and learn a little bit more about what each of our local venture firms is looking for in its next deal. It's a great pairing—wine with a venture capital twist.